BNP Paribas Financial Markets’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $399K | Buy |
7,475
+2,389
| +47% | +$127K | ﹤0.01% | 2692 |
|
2025
Q1 | $206K | Sell |
5,086
-3,396
| -40% | -$137K | ﹤0.01% | 2856 |
|
2024
Q4 | $236K | Sell |
8,482
-12,220
| -59% | -$340K | ﹤0.01% | 2943 |
|
2024
Q3 | $594K | Sell |
20,702
-8,370
| -29% | -$240K | ﹤0.01% | 2090 |
|
2024
Q2 | $682K | Sell |
29,072
-30,222
| -51% | -$709K | ﹤0.01% | 1862 |
|
2024
Q1 | $1.5M | Sell |
59,294
-152,918
| -72% | -$3.86M | ﹤0.01% | 1664 |
|
2023
Q4 | $4.96M | Buy |
212,212
+152,691
| +257% | +$3.57M | 0.01% | 970 |
|
2023
Q3 | $3.01M | Buy |
59,521
+24,047
| +68% | +$1.22M | ﹤0.01% | 1161 |
|
2023
Q2 | $1.66M | Sell |
35,474
-29,043
| -45% | -$1.36M | ﹤0.01% | 1368 |
|
2023
Q1 | $2.47M | Buy |
64,517
+26,757
| +71% | +$1.02M | ﹤0.01% | 1229 |
|
2022
Q4 | $2.07M | Buy |
37,760
+23,142
| +158% | +$1.27M | ﹤0.01% | 1222 |
|
2022
Q3 | $498K | Sell |
14,618
-7,780
| -35% | -$265K | ﹤0.01% | 2318 |
|
2022
Q2 | $212K | Buy |
22,398
+15,817
| +240% | +$149K | ﹤0.01% | 2437 |
|
2022
Q1 | $93.4K | Buy |
6,581
+885
| +16% | +$12.6K | ﹤0.01% | 2805 |
|
2021
Q4 | $120K | Buy |
5,696
+898
| +19% | +$19K | ﹤0.01% | 2903 |
|
2021
Q3 | $107K | Buy |
4,798
+3,857
| +410% | +$86.2K | ﹤0.01% | 2654 |
|
2021
Q2 | $23.3K | Sell |
941
-781
| -45% | -$19.4K | ﹤0.01% | 2899 |
|
2021
Q1 | $50K | Buy |
1,722
+393
| +30% | +$11.4K | ﹤0.01% | 3043 |
|
2020
Q4 | $34.3K | Sell |
1,329
-1,752
| -57% | -$45.2K | ﹤0.01% | 3052 |
|
2020
Q3 | $94.9K | Buy |
3,081
+2,651
| +617% | +$81.6K | ﹤0.01% | 2530 |
|
2020
Q2 | $10.7K | Sell |
430
-2,045
| -83% | -$51K | ﹤0.01% | 3051 |
|
2020
Q1 | $52.5K | Buy |
2,475
+1,913
| +340% | +$40.6K | ﹤0.01% | 2904 |
|
2019
Q4 | $12.5K | Sell |
562
-42
| -7% | -$932 | ﹤0.01% | 3431 |
|
2019
Q3 | $13.7K | Buy |
+604
| New | +$13.7K | ﹤0.01% | 3447 |
|